NasdaqGS - Delayed Quote • USD
Inogen, Inc. (INGN)
At close: April 24 at 4:00 PM EDT
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Michael J. Bourque | Executive VP, CFO & Treasurer | -- | -- | 1963 |
Mr. Philip Corrin | Senior Vice President of Operations & Supply Chain | -- | -- | -- |
Ms. Jennifer Yi Boyer | Executive VP & Chief Human Resources Officer | -- | -- | -- |
Mr. Vijay Paliwal | Senior Vice President of Enterprise Enablement | -- | -- | -- |
Mr. Grgoire Ramade | Executive VP & Chief Commercial Officer | -- | -- | 1970 |
Inogen, Inc.
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 834
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Corporate Governance
Inogen, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 5. The pillar scores are Audit: 2; Board: 5; Shareholder Rights: 8; Compensation: 6.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- Apr 18, 2024ARS: Annual Report to ShareholdersSee Full Filing
- Apr 15, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Mar 01, 2024S-8: Offering RegistrationsSee Full Filing
- Feb 27, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Jan 24, 20248-K: Corporate Changes & Voting MattersSee Full Filing
Upcoming Events
May 07, 2024
Inogen, Inc. Earnings Call
Related Tickers
SGHT Sight Sciences, Inc.
5.62
-0.35%
LUNG Pulmonx Corporation
7.52
+0.27%
MODD Modular Medical, Inc.
1.5800
+0.64%
CVRX CVRx, Inc.
14.40
+0.77%
OFIX Orthofix Medical Inc.
13.56
+2.57%
MXCT MaxCyte, Inc.
3.7400
-1.58%
FNA Paragon 28, Inc.
9.64
-4.08%
LIVN LivaNova PLC
55.94
+1.67%
AXGN AxoGen, Inc.
6.87
-1.43%
CTKB Cytek Biosciences, Inc.
5.66
-2.58%